litlas
ログインアカウント作成

David A. Cooper

1977–2024 年に発表

173
論文数
37,753
被引用数
106
h 指数
171
i10 指数

被引用数

David A. Cooper の年別被引用数1978 年: 被引用 2 件1979 年: 被引用 2 件1980 年: 被引用 2 件1983 年: 被引用 3 件1984 年: 被引用 1 件1985 年: 被引用 6 件1986 年: 被引用 7 件1987 年: 被引用 5 件1988 年: 被引用 2 件1989 年: 被引用 4 件1990 年: 被引用 6 件1991 年: 被引用 19 件1992 年: 被引用 12 件1993 年: 被引用 41 件1994 年: 被引用 38 件1995 年: 被引用 37 件1996 年: 被引用 69 件1997 年: 被引用 114 件1998 年: 被引用 202 件1999 年: 被引用 246 件2000 年: 被引用 352 件2001 年: 被引用 393 件2002 年: 被引用 400 件2003 年: 被引用 420 件2004 年: 被引用 415 件2005 年: 被引用 345 件2006 年: 被引用 299 件2007 年: 被引用 289 件2008 年: 被引用 297 件2009 年: 被引用 373 件2010 年: 被引用 280 件2011 年: 被引用 280 件2012 年: 被引用 215 件2013 年: 被引用 212 件2014 年: 被引用 145 件2015 年: 被引用 134 件2016 年: 被引用 162 件2017 年: 被引用 119 件2018 年: 被引用 105 件2019 年: 被引用 493 件2020 年: 被引用 463 件2021 年: 被引用 429 件2022 年: 被引用 378 件2023 年: 被引用 284 件2024 年: 被引用 347 件2025 年: 被引用 183 件2026 年: 被引用 22 件1981〜1982 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,348 件、この内訳の 31.4%イギリス: 引用元論文 781 件、この内訳の 7.3%オーストラリア: 引用元論文 556 件、この内訳の 5.2%フランス: 引用元論文 501 件、この内訳の 4.7%カナダ: 引用元論文 449 件、この内訳の 4.2%ドイツ: 引用元論文 439 件、この内訳の 4.1%イタリア: 引用元論文 391 件、この内訳の 3.7%中国: 引用元論文 367 件、この内訳の 3.4%スペイン: 引用元論文 327 件、この内訳の 3.1%オランダ: 引用元論文 323 件、この内訳の 3%スイス: 引用元論文 295 件、この内訳の 2.8%南アフリカ: 引用元論文 214 件、この内訳の 2%
0%31.4%その他 25.1%

機関

分野

  • Medicine50.9%
  • Immunology and Microbiology24.8%
  • Computer Science13.8%
  • Biochemistry, Genetics and Molecular Biology4.1%
  • Environmental Science1.8%
  • Engineering1%
  • その他3.6%

トピック

  • HIV Research and Treatment14.1%
  • HIV/AIDS drug development and treatment10.5%
  • HIV/AIDS Research and Interventions10.4%
  • HIV-related health complications and treatments7.6%
  • Immune Cell Function and Interaction3%
  • Cryptography and Data Security2.4%
  • その他52%

共著者

全論文

検索で開く
  1. Status report on the third round of the NIST Post-Quantum Cryptography Standardization process

    著者: Gorjan Alagic, Daniel Apon, David A. Cooper, Quynh Dang, Thinh Dang, John Kelsey, Jacob Lichtinger, Yi-Kai Liu, Carl A. Miller, Dustin Moody, René Peralta, Ray Perlner, Angela Robinson, Daniel Smith-Tone - National Institute of Standards and Technology 2022 被引用: 365

  2. Status report on the first round of the NIST post-quantum cryptography standardization process

    著者: Gorjan Alagic, Jacob Alperin-Sheriff, Daniel Apon, David A. Cooper, Quynh Dang, Yi-Kai Liu, Carl A. Miller, Dustin Moody, René Peralta, Ray Perlner, Angela Robinson, Daniel Smith-Tone - National Institute of Standards and Technology 2019 被引用: 355

  3. Status report on the second round of the NIST post-quantum cryptography standardization process

    著者: Dustin Moody, Gorjan Alagic, Daniel Apon, David A. Cooper, Quynh H Dang, John Kelsey, Yi-Kai Liu, Carl A. Miller, René Peralta, Ray A Perlner, Angela Robinson, Daniel Smith-Tone, Jacob Alperin-Sheriff - National Institute of Standards and Technology 2020 被引用: 291

  4. Recommendation for Stateful Hash-Based Signature Schemes

    著者: David A. Cooper, Daniel Apon, Quynh Dang, Michael Davidson, Morris J. Dworkin, Carl A. Miller - National Institute of Standards and Technology 2020 被引用: 89

  5. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study

    著者: Benjamin R. Bavinton, Angie N. Pinto, Nittaya Phanuphak, Beatriz Grinsztejn, Garrett P Prestage, Iryna Zablotska, Fengyi Jin, Christopher K. Fairley, Richard D. Moore, Norman Roth, Mark Bloch, Catherine Pell, Anna McNulty, David Baker, Jennifer Hoy, Ban Kiem Tee, David J. Templeton, David A. Cooper, Sean Emery, Anthony D. Kelleher, Andrew E. Grulich, Andrew E. Grulich, Iryna Zablotska, Garrett P Prestage, Fengyi Jin, Benjamin R. Bavinton, Beatriz Grinsztejn, Nittaya Phanuphak, David A. Cooper, Anthony D. Kelleher, Sean Emery, Christopher K. Fairley, David P. Wilson, Kersten K. Koelsch, Kathy Triffitt, Nicolas Doong, David Baker, Mark Bloch, David J. Templeton, Anna McNulty, Catherine Pell, Jennifer Hoy, Ban Kiem Tee, Richard D. Moore, Norman Roth, David N. Orth, Angie N. Pinto - The Lancet HIV 2018 被引用: 519

  6. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study

    著者: Andrew E. Grulich, Rebecca Guy, Janaki Amin, Fengyi Jin, Christine Selvey, Jo Holden, H Schmidt, Iryna Zablotska, Karen Price, Bill Whittaker, Kerry Chant, Craig Cooper, Scott McGill, Barbara Telfer, Barbara Yeung, Gesalit Levitt, Erin Ogilvie, Nila J. Dharan, Mohamed Hammoud, Stefanie Vaccher, Lucy Watchirs-Smith, Anna McNulty, David J. Smith, Debra Allen, David Baker, Mark Bloch, Rohan I. Bopage, Katherine Brown, Andrew Carr, Christopher Carmody, Kym L Collins, Robert Finlayson, Rosalind Foster, Eva Jackson, David A. Lewis, Josephine Lusk, Catherine OʼConnor, Nathan Ryder, Emanuel Vlahakis, Phillip Read, David A. Cooper, Don Smith, Catriona Ooi, Sarah Martin, Tuck Meng Soo, David J. Templeton, David H. Townson, Brad Forssman, Nick Doong, Gai Han Thai, Ben Anderson, Hugh MacLeod, Nicolas Parkhill - The Lancet HIV 2018 被引用: 369

  7. HIV-1 DNA predicts disease progression and post-treatment virological control

    著者: James P. Williams, Jacob Hurst, Wolfgang Stöhr, Nicola Robinson, Helen Brown, Martin Fisher, Sabine Kinloch, David A. Cooper, Mauro Schechter, Giuseppe Tambussi, Sarah Fidler, Mary Carrington, Abdel Babiker, Jonathan Weber, Kersten K. Koelsch, Anthony D. Kelleher, Rodney E. Phillips, John Frater, on behalf of the SPARTAC trial investigators - eLife 2014 被引用: 307

  8. Characterization of CD4+ CTLs Ex Vivo

    著者: Victor Appay, John Zaunders, Laura Papagno, Julian Sutton, Angel Jaramillo, Anele Waters, Philippa Easterbrook, Pat Grey, Don Smith, Andrew J. McMichael, David A. Cooper, Sarah Rowland‐Jones, Anthony D. Kelleher - The Journal of Immunology 2002 被引用: 540

  9. Quantum resistant public key cryptography: a survey

    著者: Ray A. Perlner, David A. Cooper - Symposium on Identity and Trust on the Internet, IDtrust 2009 被引用: 137

  10. High Levels of Human Antigen-Specific CD4+ T Cells in Peripheral Blood Revealed by Stimulated Coexpression of CD25 and CD134 (OX40)

    著者: John Zaunders, C. Mee Ling Munier, Nabila Seddiki, Sarah Pett, Susanna Ip, Michelle Bailey, Yin Xu, Kai Brown, Wayne B. Dyer, Min Kim, Robert De Rose, Stephen J. Kent, Lele Jiang, Samuel N. Breit, Sean Emery, Anthony L. Cunningham, David A. Cooper, Anthony D. Kelleher - The Journal of Immunology 2009 被引用: 180

  11. Guidelines for the selection, configuration, and use of Transport Layer Security (TLS) implementations

    著者: Kerry A. McKay, David A. Cooper - National Institute of Standards and Technology 2019 被引用: 52

  12. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

    著者: Andrew Carr, Katherine Samaras, Samantha Burton, Matthew Law, Judith Freund, Donald J. Chisholm, David A. Cooper - AIDS 1998 被引用: 2,403

  13. Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

    著者: Ronald T. Mitsuyasu, Thomas C. Merigan, Andrew Carr, Jerome A. Zack, Mark A. Winters, Cassy Workman, Mark Bloch, Jacob Lalezari, S. Hegewisch Becker, Lorna Thornton, Bisher Akil, Homayoon Khanlou, Robert Finlayson, Robert McFarlane, Don Smith, Roger Garsia, Dávid Ma, Matthew Law, John M. Murray, Christof von Kalle, Julie A. Ely, Sharon M Patino, Alison E. Knop, Philip Wong, Alison V. Todd, Margaret Haughton, C.J. Fuery, Janet L. Macpherson, Geoff Symonds, Louise Evans, Susan M. Pond, David A. Cooper - Nature Medicine 2009 被引用: 263

  14. Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

    著者: Jacob Hurst, Matthias Hoffmann, Matthew Pace, James P. Williams, John Thornhill, Elizabeth Hamlyn, Jodi Meyerowitz, Chris Willberg, Kersten K. Koelsch, Nicola Robinson, Helen Brown, Martin Fisher, Sabine Kinloch, David A. Cooper, Mauro Schechter, Giuseppe Tambussi, Sarah Fidler, Abdel Babiker, Jonathan Weber, Anthony D. Kelleher, Rodney E. Phillips, John Frater - Nature Communications 2015 被引用: 178

  15. Recommendation for Stateful Hash-Based Signature Schemes

    著者: David A. Cooper - 2019 被引用: 24

  16. Relation between HIV viral load and infectiousness: a model-based analysis

    著者: David P. Wilson, Matthew Law, Andrew E. Grulich, David A. Cooper, John Kaldor - The Lancet 2008 被引用: 366

  17. Predictors of disease progression in HIV infection: a review

    著者: Simone E Langford, Jintanat Ananworanich, David A. Cooper - AIDS Research and Therapy 2007 被引用: 332

  18. HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission

    著者: Mykola Pinkevych, Deborah Cromer, Martin Tolstrup, Andrew Grimm, David A. Cooper, Sharon R. Lewin, Ole S. Søgaard, Thomas A. Rasmussen, Stephen J. Kent, Anthony D. Kelleher, Miles P. Davenport - PLoS Pathogens 2015 被引用: 119

  19. Adverse effects of antiretroviral therapy

    著者: Andrew Carr, David A. Cooper - The Lancet 2000 被引用: 1,065

  20. The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years

    著者: Mark Nelson, Christine Katlama, Joan Montaner, David A. Cooper, Brian Gazzard, Bonaventura Clotet, Adriano Lazzarin, Knud Schewe, Joep M. A. Lange, Christina Wyatt, Sue Curtis, Shan-Shan Chen, Stephen A. Smith, Norbert Bischofberger, James F. Rooney - AIDS 2007 被引用: 352

  21. Specific antibody‐dependent cellular cytotoxicity responses associated with slow progression of HIV infection

    著者: Leia Wren, Amy W. Chung, Gamze Isitman, Anthony D. Kelleher, Matthew S. Parsons, Janaki Amin, David A. Cooper, Ivan Stratov, Marjon Navis, Stephen J. Kent - Immunology 2012 被引用: 144

  22. Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging

    著者: Edwin Leeansyah, Paul Cameron, Ajantha Solomon, Surekha Tennakoon, Pushparaj Velayudham, Maëlenn Gouillou, Tim Spelman, Anna C. Hearps, Christopher K. Fairley, De Villiers Smit, Anna Pierce, Jude Armishaw, Suzanne M. Crowe, David A. Cooper, Kersten K. Koelsch, Junping Liu, John Chuah, Sharon R. Lewin - The Journal of Infectious Diseases 2013 被引用: 137

  23. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

    著者: Andrew Carr, Katherine Samaras, Donald J. Chisholm, David A. Cooper - The Lancet 1998 被引用: 1,093

  24. Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria

    著者: Katherine Samaras, Handan Wand, Matthew Law, Sean Emery, David A. Cooper, Andrew Carr - Diabetes Care 2006 被引用: 322